Combining locoregional CAR-T cells, autologous plus allogeneic tumor lysate vaccination and levamisole in treatment of glioblastoma

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAltinoz, Meric A.
dc.contributor.authorOzpinar, Alp
dc.contributor.authorHacker, Emily
dc.contributor.authorOzpinar, Aysel
dc.date.accessioned2025-10-16T15:17:16Z
dc.date.issued2022
dc.identifier.doi10.1080/08923973.2022.2086136
dc.identifier.otherWOS:000811155500001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6895
dc.publisherTAYLOR \& FRANCIS LTD
dc.sourceIMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
dc.subjectGlioblastoma
dc.subjectCAR\\-T cells
dc.subjectallogeneic cancer vaccine
dc.subjectautologous cancer vaccine
dc.subjectlevamisole
dc.titleCombining locoregional CAR-T cells, autologous plus allogeneic tumor lysate vaccination and levamisole in treatment of glioblastoma
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS